STOCK TITAN

Relay Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 2021 Oncology Day

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Relay Therapeutics (Nasdaq: RLAY) will participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Oncology Day on February 11, 2021, at 3:30 p.m. ET. The chat will be streamed live and can be accessed on the Investor page of Relay's website. An archived replay will be available for one year after the event. Relay Therapeutics focuses on precision medicine and utilizes its Dynamo platform to innovate drug discovery, particularly in targeted oncology. For more details, visit their website or follow them on Twitter.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Oncology Day on Thursday, February 11, 2021 at 3:30 p.m. ET. The fireside chat will be webcast live and may be accessed from the Investor page of Relay’s website under Events and Presentations. Within 24 hours following the fireside chat, an archived replay of the webcast will be available for up to one year.

About Relay Therapeutics

Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, Relay Therapeutics aims to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The Company’s Dynamo platform integrates an array of leading-edge experimental and computational approaches to provide a differentiated understanding of protein structure and motion to drug these targets. For more information, please visit www.relaytx.com or follow us on Twitter.

Contact:
Pete Rahmer, Head of Investor Relations and Communications
617-322-0715
prahmer@relaytx.com

Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com


FAQ

What is Relay Therapeutics scheduled to do on February 11, 2021?

Relay Therapeutics will participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Oncology Day.

How can I watch the Relay Therapeutics fireside chat live?

The fireside chat will be webcast live and can be accessed from the Investor page on Relay Therapeutics' website.

Will there be a replay of Relay Therapeutics' fireside chat?

Yes, an archived replay of the webcast will be available for up to one year following the event.

What is the focus of Relay Therapeutics?

Relay Therapeutics focuses on transforming drug discovery in precision medicine, particularly in targeted oncology.

What is the Dynamo platform used by Relay Therapeutics?

The Dynamo platform integrates experimental and computational approaches to enhance understanding of protein structure and motion for drug discovery.

Relay Therapeutics, Inc.

NASDAQ:RLAY

RLAY Rankings

RLAY Latest News

RLAY Stock Data

718.91M
163.25M
1.71%
98.27%
6.94%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE